Cyclopedic protein expression analysis of cultured canine mammary gland adenocarcinoma cells from six tumours

Research in Veterinary Science

Volumn 80, Issue 3, 2006, Pages 317-323

  Nakagawa, T ^a   Watanabe, M ^b   Ohashi, E ^a   Uyama, R ^a   Takauji, S ^a   Mochizuki, M ^a   Nishimura, R ^a   Ogawa, H ^a   Sugano, S ^b   Sasaki, N ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

14 3 3 ; Dog; Mammary gland adenocarcinoma; Protein expression; Sialyl lewis X sLe(x)

Indexed keywords

ALPHA TUBULIN; ANTIGEN NCC ST 439; BETA ACTIN; BETA CATENIN; CARBOHYDRATE ANTIGEN; CYCLIN D1; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOPROTEIN PHOSPHATASE 2A; PROLACTIN; PROLACTIN R; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 GAMMA; PROTEIN 14 3 3 SIGMA; PROTEIN 14 3 3 TAU; PROTEIN 14 3 3 TETA; PROTEIN 14 3 3 ZETA; PROTEIN P53; RETINOBLASTOMA PROTEIN; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER DIAGNOSIS; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; METASTASIS; MOLECULAR BIOLOGY; NONHUMAN; PLEURA EFFUSION; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

14-3-3 PROTEINS; ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CYCLIN D1; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM PROTEINS; OLIGOSACCHARIDES; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

ANIMALIA; CANIS FAMILIARIS;

EID: 32044456993     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2005.07.011     Document Type: Article

References (44)

1. M. Barbareschi P. Pelosio O. Caffo F. Buttitta S. Pellegrini R. Barbazza P. Dalla Palma G. Bevilacqua A. Marchetti Cyclin-D1-gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression Int. J. Cancer 74 1997 171-174
2. E.L. Berg M.K. Robinson O. Mansson E.C. Butcher J.L. Magnani A carbohydrate domain common to both sialyl Le(a) and sialyl Le(x) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1 J. Biol. Chem. 266 1991 14869-14872
3. R.S. Brodey M.H. Goldschmidt J.R. Roszel Canine mammary gland neoplasms J. Am. Anim. Hosp. Assoc. 19 1983 61-90
4. C.R. Dorn D.O. Taylor R. Schneider H.H. Hibbard M.R. Klauber Survey of animal neoplasms in Alameda and Contra Costa Counties, California J. Natl. Cancer I. 40 1968 307-318
5. T. Dubois S. Howell B. Amess P. Kerai M. Learmonth J. Madrazo M. Chaudhri K. Rittinger M. Scarabel Y. Soneji A. Aitken Structure and sites of phosphorylation of 14-3-3 protein: Role in coordinating signal transduction pathways J. Protein Chem. 16 1997 513-522
6. 6) in normal and tumor tissues defined by its monoclonal antibody FH6 Cancer Res. 45 1985 3711-3717
7. X as a new tumor-associated antigen Cancer Res. 44 1984 5279-5285
8. M. Gion R. Mione A.E. Leon R. Dittadi Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer Clin. Chem. 45 1999 630-637
9. K.A. Hahn R.C. Richardson D.W. Knapp Canine malignant mammary neoplasia: Biologic behavior, diagnosis and treatment alternatives J. Am. Anim. Hosp. Assoc. 28 1992 251-256
10. E. Hellmen A. Lindgren The expression of intermediate filaments in canine mammary glands and their tumors Veterinary Pathology 26 1989 420-428
11. L.R. Howe A.M. Brown Wnt signaling and breast cancer Cancer Biol. & Ther. 3 2004 36-41
12. I. Issemann S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645-650
13. P. Jares M.J. Rey P.L. Fernandez E. Campo A. Nadal M. Munoz C. Mallofre J. Muntane I. Nayach J. Estape A. Cardesa Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: Correlation with tumor proliferation and estrogen receptor status J. Pathol. 182 1997 160-166
14. T.C. Jones R.D. Hunt N.W. King Mammary gland T.C. Jones R.D. Hunt N.W. King Vet. Pathol. sixth ed. 1997 Williams & Wilkins Baltimore 1190-1198
15. V.G. Keshamouni R.C. Reddy D.A. Arenberg B. Joel V.J. Thannickal G.P. Kalemkerian T.J. Standiford Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer Oncogene 23 2004 100-108
16. S. Kitamura Y. Miyazaki Y. Shinomura S. Kondo S. Kanayama Y.. Matsuzawa Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells Jpn. J. Cancer Res. 90 1999 75-80
17. I.D. Kurzman S.R. Gilbertson Prognostic factors in canine mammary tumors Semin. Vet. Med. & Surg. (Small Animal) 1 1986 25-32
18. C.H. Lee W.H. Kim J.H. Lim M.S. Kang D.Y. Kim O.K. Kweon Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors J. Vet. Med. Sci. 5 2004 63-69
19. J.B. Lowe L.M. Stoolman R.P. Nair R.D. Larsen T.L. Berhend R.M. Marks ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA Cell 63 1990 475-484
20. E.G. MacEwen S.J. Withrow Tumors of the mammary gland S.J. Withrow E.G. MacEwen Small Animal Clinical Oncology second ed. 1996 Saunders Co Philadelphia: WB 356-372
21. W. Misdorp R.W. Else E. Hellmén T.P. Lipscomb In: Histological classification of mammary tumors of the dog and cat WHO International Histological Classification of Tumors in Domestic Animals 2nd series vol. VII 1999 Armed Forces Institute of Pathology Washington, DC
22. R. Moll Cytokeratins in the histological diagnosis of malignant tumors Int. J. Biol. Marker. 9 1994 63-69
23. W. Motomura M. Nagamine S. Tanno M. Sawamukai N. Takahashi Y. Kohgo T. Okumura Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells J. Gastroenterol. 39 2004 461-468
24. E. Mueller P. Sarraf P. Tontonoz R.M. Evans K.J. Martin M. Zhang C. Fletcher S. Singer B.M. Spiegelman Terminal differentiation of human breast cancer through PPAR gamma Mol. Cell 1 1998 465-470
25. T. Nakagawa R. Uyama E. Ohashi T. Takahashi S.H. Hong M. Mochizuki S. Matsunaga R. Nishimura N. Sasaki The expression of sialyl Lewis X in canine and feline mammary gland tumors J. Vet. Med. Sci. 64 2002 949-952
26. X antigen in relation to survival of patients with colorectal carcinoma Cancer 72 1993 2323-2330
27. T. Nakagoe K. Fukushima T. Tuji T. Sawai A. Nanashima H. Yamaguchi T. Yasutake S. Hara H. Ayabe T. Matuo S. Kamihira Immunohistochemical expression of ABH/Lewis-related antigens in primary breast carcinomas and metastatic lymph node lesions Cancer Detect. & Prev. 22 1998 499-505
28. T. Narita H. Funahashi Y. Satoh H. Takagi Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis Jpn. J. Clin. Oncol. 23 1993 20-25
29. T. Narita H. Funahashi Y. Satoh T. Imai H. Takagi Serum and immunohistochemical studies of NCC-ST-439 in breast cancer J. Surg. Oncol. 54 1993 5-8
30. L.N. Owen Classification of Tumors in Domestic Animals first ed. 1980 World Health Organization Geneva
31. M.L. Phillips E. Nudelman F.C. Gaeta M. Perez A.K. Singhal S. Hakomori J.C. Paulson ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex Science 250 1990 1130-1132
32. J. Renkonen T. Paavonen R. Renkonen Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesion of breast carcinoma Int. J. Cancer 74 1997 296-300
33. B. Restucci S. Papparella G. De Vico P. Maiolino E cadherin expression in normal and neoplastic canine mammary gland J. Comp. Pathol. 116 1997 191-202
34. J.S. Ross J.A. Fletcher The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy Stem Cells 16 1998 413-428
35. A. Sawan B. Randall B. Angus C. Wright J.A. Henry J. Ostrowski C. Hennessy T.W. Lennard I. Corbett C.H. Horne Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: An immunohistochemical study J. Pathol. 168 1992 23-28
36. C.J. Sherr Cancer cell cycles Science 274 1996 1672-1677
37. F.S. Shofer E.G. Sonnenschein M.H. Goldschmidt L.L. Laster L.T. Glickman Histopathologic and dietary prognostic factors for canine mammary carcinoma Breast Cancer Res. Tr. 13 1989 49-60
38. D.J. Slamon G.M. Clark S.G. Wong W.J. Levin A. Ullrich W.L. McGuire Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177-182
39. D.J. Slamon W. Godolphin L.A. Jones J.A. Holt S.G. Wong D.E. Keith W.J. Levin S.G. Stuart J. Udove A. Ullrich Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707-711
40. K. Sugiyama T. Kawai N. Nagata M. Suzuki Tumor-associated carbohydrate antigens in primary pulmonary adenocarcinomas and their metastasis Hum. Pathol. 23 1992 900-904
41. G.A. Turner Surface properties of the metastatic cell Invas. & Metast. 2 1982 197-216
42. T. Urano T. Saito T. Tsukui M. Fujita T. Hosoi M. Muramatsu Y. Ouchi S. Inoue Efp targets 14-3-3 sigma for proteolysis and promotes breast tumor growth Nature 417 2002 871-875
43. K. Vleminckx L. Vakaet Jr. M. Mareel W. Fiers F. van Roy Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role Cell 66 1991 107-119
44. R. Yoshimura M. Matsuyama T. Hase K. Tsuchida K. Kuratsukuri Y. Kawahito H. Sano Y. Segawa T. Nakatani The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells Int. J. Mol. Med. 12 2003 861-865